MARKET

CHRS

CHRS

Coherus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.16
-0.71
-3.55%
After Hours: 19.16 0 0.00% 16:30 01/17 EST
OPEN
19.96
PREV CLOSE
19.87
HIGH
19.96
LOW
18.98
VOLUME
833.38K
TURNOVER
--
52 WEEK HIGH
23.91
52 WEEK LOW
10.83
MARKET CAP
1.34B
P/E (TTM)
-99.7397
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CHRS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CHRS News

  • Arena's (ARNA) Heart Failure Candidate Gets Fast Track Status
  • Zacks.18h ago
  • Coherus acquires U.S. rights to Avastin biosimilar
  • Seeking Alpha - Article.4d ago
  • Coherus Acquires Commercial Rights for Avastin® Biosimilar in the United States
  • GlobeNewswire.4d ago
  • Breakout Stocks & Technical Analysis
  • Investor's Business Daily.01/08 17:00

More

Industry

Biotechnology & Medical Research
-0.10%
Pharmaceuticals & Medical Research
+0.07%

Hot Stocks

Name
Price
%Change

About CHRS

Coherus BioSciences, Inc. is a late-stage clinical biologics platform company. The Company is engaged in the business of developing and commercializing biosimilar products. The Company's business is organized around therapeutic franchises, including Oncology biosimilar candidates pegfilgrastim (Neulasta) and bevacizumab (Avastin); Immunology (Anti-TNF) biosimilar candidates etanercept (Enbrel) and adalimumab (Humira); Ophthalmology biosimilar candidate ranibizumab (Lucentis), and Multiple sclerosis small molecule therapeutic candidate, CHS-131. The Company's product candidate pipeline includes CHS-1701, CHS-5217, CHS-0214, CHS-1420 and CHS-3351. Its CHS-1701 is a Granulocyte colony-stimulating factor (G-CSF) product candidate. Its Bevacizumab is a recombinant humanized monoclonal antibody that blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A). Its Etanercept (Enbrel) is the reference product for CHS-0214.
More

Webull offers Coherus Biosciences Inc (CHRS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.